Using Bearing nsPVA particles for treating uterine fibroids

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect data on the safety and performance outcomes of Bearing nsPVA Embolization Particles used in uterine artery embolization for symptomatic uterine fibroids. It involves adult women who meet specific eligibility criteria and will follow participants for six months post-treatment. The study is multicenter and focuses on real-world outcomes following the use of this embolization technique.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult women ≥ 18 years old at the time of enrollment.
* Subject has symptomatic uterine fibroid(s), suitable to embolization.
* Subject provides written informed consent.

Exclusion Criteria:

* Subject is pregnant.
* Subject has suspected pelvic inflammatory disease or any other pelvic infection.
* Subject has any malignancy of the pelvic region, (e.g., endometrial neoplasia).

Where it's running

• The Wesley Hospital
  Brisbane, Australia Recruiting
• Alfred Health
  Sydney, Australia Recruiting
• Royal Gwent Hospital (Aneurin Bevan UHB)
  Newport, United Kingdom Recruiting
• Astra Vascular/Astra Vein Treatment Center
  Brooklyn, New York, United States Active not recruiting

Study contacts

• Study coordinator: Molly Ryan
• Email: molly.ryan@merit.com
• Phone: 314-620-7095

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Relugolix (Ryeqo) with low‑dose add-back hormones for uterine fibroids and endometriosis and its effects on blood clotting

  This trial will test whether the GnRH antagonist Relugolix combined with low‑dose estradiol and progestin (Ryeqo) changes blood clotting markers in adult women treated for uterine fibroids or endometriosis.

  Recruiting University Hospital, Geneva · Geneva, Canton of Geneva · NCT07173127

• Evaluating uterine fibroids using ultrasound techniques before and after treatment

  This study is testing if a special ultrasound can help women with uterine fibroids see how their condition changes before and after a specific treatment called uterine artery embolization.

  Recruiting Phase 2 Thomas Jefferson University · Philadelphia, Pennsylvania · NCT06705075

• Impact of Uterine Fibroids on Women's Fertility

  This study looks at how uterine fibroids might affect pregnancy rates in women aged 20-50 who are struggling with infertility.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06020924

• Uterine Fibroids in China: How Common They Are and What Increases Risk

  This study tests how common uterine fibroids are in Chinese women and what factors relate to developing them and needing surgery.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT05840042

• Registry for pregnancy outcomes after Exablate treatment for uterine fibroids

  This study is looking to see how the Exablate treatment for uterine fibroids affects pregnancy outcomes in people who have had the procedure.

  Recruiting at 5 sites InSightec · Los Angeles, California and 5 other locations · NCT05386615

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.